Daniel Swisher
Chairman at CERUS CORPORATION
Net worth: 7 M $ as of 2024-03-30
Daniel Swisher active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CERUS CORPORATION | Independent Dir/Board Member | 2011-05-31 | - |
| Chairman | 2013-09-30 | - | |
| Director/Board Member | 2011-06-29 | 2013-09-30 | |
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 2015-06-17 | - |
| Independent Dir/Board Member | 2015-06-17 | - | |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 2023-10-25 | - |
Career history of Daniel Swisher
Former positions of Daniel Swisher
| Companies | Position | Start | End |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 2018-01-02 | 2021-05-04 |
| President | 2018-01-02 | 2023-09-30 | |
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2011-06-06 | 2017-12-30 |
| Chief Executive Officer | 2001-11-30 | 2017-12-30 | |
| Director of Finance/CFO | 2017-04-26 | 2017-11-29 | |
| President | 2001-11-30 | 2017-12-30 | |
| Corporate Secretary | 2017-04-06 | 2017-12-30 | |
| ALZA CORPORATION | Sales & Marketing | 1992-05-31 | 2001-08-31 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Operating Officer | 2017-12-31 | - |
| President | 2017-12-31 | - |
Training of Daniel Swisher
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistics
International
| United States | 9 |
| Ireland | 2 |
Operational
| Director/Board Member | 4 |
| President | 3 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| CERUS CORPORATION | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private companies | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Daniel Swisher
- Experience
